KPTI Karyopharm Therapeutics Inc

Karyopharm Therapeutics Inc. is a clinical-stage pharmaceutical company. It focuses on the discovery, development, and commercialization of first-in-class drugs directed against nuclear transport and related targets to treat cancer and other diseases.

$13.75  -0.07 (-0.51%)
As of 03/01/2021 15:59:57 EST     IEX book   CBOE book


Security Information
Category1:
Category2:
Category3:
GICS sector:
Industry:
Index country:
Country of incorporation:
IPO date:
Outstanding shares:
Average volume:
Market cap:
Current dividend yield:
All SEC filings:
Quarterly filings:
Annual filings:
CUSIP:
ISIN:
Sedol:
US Equity
Common stocks
Small cap
Health Care
Biotechnology
USA
USA
11/06/2013
73,600,777
3,187,306
$1,017,162,738
0.00%
SEC Edgar Online
10-Q
10-K
48576U106
US48576U1060
BG3FZW0

Valuation   (See tab for details)
PE ratio:
PB ratio:
PS ratio:
Return on equity:
Net income %:
-5.18
20.20
9.41
-388.31%
-181.59%

2021 © Stock Market MBA, Inc. Terms of use | Privacy policy